Showing 1 - 20 results of 37 for search 'Angelo Avogaro', query time: 0.06s Refine Results
  1. 1
    Mechanisms of cardiovascular protection of non-insulin antidiabetic medications

    Mechanisms of cardiovascular protection of non-insulin antidiabetic medications by Angelo Avogaro

    Published 2018-11-01
    Get full text
    Article
  2. 2
    How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors

    How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors by Gian Paolo Fadini, Angelo Avogaro

    Published 2018-02-01
    Get full text
    Article
  3. 3
    Diabetic retinopathy: a tool for cardiovascular risk stratification

    Diabetic retinopathy: a tool for cardiovascular risk stratification by Angelo Avogaro, Gian Paolo Fadini

    Published 2019-12-01
    Get full text
    Article
  4. 4
    La gestione del paziente diabetico tra presente e futuro

    La gestione del paziente diabetico tra presente e futuro by Angelo Avogaro, Antonio C. Bossi

    Published 2017-10-01
    Get full text
    Article
  5. 5
    Genetic Diagnosis in a Cohort of Adult Patients with Inherited Metabolic Diseases: A Single-Center Experience

    Genetic Diagnosis in a Cohort of Adult Patients with Inherited Metabolic Diseases: A Single-Center Experience by Livia Lenzini, Gianni Carraro, Angelo Avogaro, Nicola Vitturi

    Published 2022-06-01
    Get full text
    Article
  6. 6
    Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown

    Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown by Federico Boscari, Sara Ferretto, Ambra Uliana, Angelo Avogaro, Daniela Bruttomesso

    Published 2021-01-01
    Get full text
    Article
  7. 7
    SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system

    SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system by Benedetta Maria Bonora, Emanuel Raschi, Angelo Avogaro, Gian Paolo Fadini

    Published 2021-02-01
    Get full text
    Article
  8. 8
    Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis

    Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis by Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Angelo Avogaro, Gian Paolo Fadini

    Published 2022-08-01
    Get full text
    Article
  9. 9
    Identification of diabetic neuropathic patients at risk of foot ulceration through finite element models and cluster analysis

    Identification of diabetic neuropathic patients at risk of foot ulceration through finite element models and cluster analysis by Annamaria Guiotto, Zimi Sawacha, Alessandra Scarton, Gabriella Guarneri, Angelo Avogaro, Claudio Cobelli

    Published 2014-01-01
    Get full text
    Article
  10. 10
    2‐Dimensional foot FE models for clinical application in gait analysis

    2‐Dimensional foot FE models for clinical application in gait analysis by Alessandra Scarton, Annamaria Guiotto, Zimi Sawacha, Gabriella Guarneri, Angelo Avogaro, Claudio Cobelli

    Published 2014-01-01
    Get full text
    Article
  11. 11
    Biomechanical evaluation of diabetic foot through hierarchical cluster analysis

    Biomechanical evaluation of diabetic foot through hierarchical cluster analysis by Zimi Sawacha, Fabiola Spolaor, Gabriella Guarneri, Annamaria Guiotto, Angelo Avogaro, Claudio Cobelli

    Published 2014-01-01
    Get full text
    Article
  12. 12
    Urine-Derived Epithelial Cells as a New Model to Study Renal Metabolic Phenotypes of Patients with Glycogen Storage Disease 1a

    Urine-Derived Epithelial Cells as a New Model to Study Renal Metabolic Phenotypes of Patients with Glycogen Storage Disease 1a by Livia Lenzini, Elisabetta Iori, Federico Scannapieco, Gianni Carraro, Angelo Avogaro, Nicola Vitturi

    Published 2022-12-01
    Get full text
    Article
  13. 13
    Glucose and fatty acid metabolism in a 3 tissue in-vitro model challenged with normo- and hyperglycaemia.

    Glucose and fatty acid metabolism in a 3 tissue in-vitro model challenged with normo- and hyperglycaemia. by Elisabetta Iori, Bruna Vinci, Ellen Murphy, Maria Cristina Marescotti, Angelo Avogaro, Arti Ahluwalia

    Published 2012-01-01
    Get full text
    Article
  14. 14
    Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study

    Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study by Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, Gian Paolo Fadini

    Published 2021-11-01
    Get full text
    Article
  15. 15
    Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice

    Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice by Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, Gian Paolo Fadini

    Published 2020-06-01
    Get full text
    Article
  16. 16
    Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care

    Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care by Mario Luca Morieri, Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Angelo Avogaro, Gian Paolo Fadini

    Published 2022-12-01
    Get full text
    Article
  17. 17
    High prolactin levels in dihydropteridine reductase deficiency: A sign of therapy failure or additional pathology?

    High prolactin levels in dihydropteridine reductase deficiency: A sign of therapy failure or additional pathology? by Nicola Vitturi, Livia Lenzini, Concetta Luisi, Miryam Carecchio, Giorgia Gugelmo, Francesco Francini‐Pesenti, Angelo Avogaro

    Published 2021-09-01
    Get full text
    Article
  18. 18
    p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications

    p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications by Gian Paolo Fadini, Mattia Albiero, Benedetta Maria Bonora, Nicol Poncina, Saula Vigili de Kreutzenberg, Angelo Avogaro

    Published 2018-01-01
    Get full text
    Article
  19. 19
    Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes

    Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes by Mario Luca Morieri, Olga Lamacchia, Enzo Manzato, Andrea Giaccari, Angelo Avogaro, Lipid-Lowering-Relevance Study Group

    Published 2022-05-01
    Get full text
    Article
  20. 20
    Systemic and vascular inflammation in an in-vitro model of central obesity.

    Systemic and vascular inflammation in an in-vitro model of central obesity. by Arti Ahluwalia, Alessandra Misto, Federico Vozzi, Chiara Magliaro, Giorgio Mattei, Maria Cristina Marescotti, Angelo Avogaro, Elisabetta Iori

    Published 2018-01-01
    Get full text
    Article

Search Tools: